Clay Siegall

Board Member at Shattuck Labs
Greater Seattle Area

Clay Siegall is President and CEO at Immunome, Inc. and serves as a Board Member at Shattuck Labs. He previously founded Seagen, which was acquired, and has held leadership roles at Morphimmune, Seagen, and Tourmaline Bio.

  • Shattuck Labs Board Member 2024–present · current
  • Immunome President and CEO 2023–present, CEO and President · current
  • Seagen President and CEO 1998–2022, Co-founder 2022, Former CEO 2022 · current
  • Morphimmune President and CEO 2023 · past
  • Tourmaline Bio Chairman 2023–2025 · past

Education

  • The George Washington University Doctor of Philosophy - PhD, Genetics
  • University of Maryland Bachelor of Science - BS, Zoology

Organizations

See all 5
  • Shattuck Labs Board Member 2024–present · current
  • Immunome President and CEO 2023–present, CEO and President · current
  • Seagen President and CEO 1998–2022, Co-founder 2022, Former CEO 2022 · current

Education

  • The George Washington University Doctor of Philosophy - PhD, Genetics
  • University of Maryland Bachelor of Science - BS, Zoology

Online